External factors
| External factors: |
High glucose |
| Phenotype: |
Type 2 diabetes mellitus |
| Experiment: |
SA-β-gal activity assay |
| Description: |
Exposure of EPCs with either 25 mM glucose or 200 uM FFA for 3 days significantly increased the percentage of SA-β-gal EPCs compared with control group. Furthermore, EPCs incubation to combined stimuli displayed much higher percentage of senescent cells. |
Warning: Undefined variable $target_genes in
/data/html/Aging-ReG/public/browse_detail_2.php on line
385
Regulatory relationship
| Regulatory pathway:
|
PGC-1α-SIRT1//SIRT1-p53-p21//p38 |
| R-EF-Pathway:
|
--//Activation//-- |
| Official symbol(s): |
Warning: Undefined variable $name_all in /data/html/Aging-ReG/public/browse_detail_2.php on line 525
PPARGC1A-SIRT1//SIRT1-CDKN1A-TP53//MAPK14
|
| Pathway experiment: |
Western blot//qRT-PCR//RT-PCR |
| Pathway description: |
EPCs exposed to 48 h of combined stimuli exhibited significant increase in PGC-1α mRNA and protein levels.SIRT1 mRNA and protein levels in EPCs were significantly decreased after 2 days incubation with combined stimuli relative to control cells. SIRT1 mRNA and protein levels in EPCs were significantly decreased after 2 days incubation with combined stimuli relative to control cells. We also found that mRNA and protein levels of P53 and P21 increased significantly when compared to control cells.The effect of high glucose and FFA induced protein expression of PGC-1α were compromised by P38 MAPK inhibitor SB230580 significantly, while ERK MAPK inhibitor U0126 and JNK MAPK inhibitor SP600125 didn t have the same effects . |
Aging network
Annotation:
The green line represents Upregulation.
The purple line represents Downregulation.
The orange line represents Activation.
The yellow line represents Inhibition.
The gray line represents Unclear.